Center for Genomic Interpretation – Trademark Portfolio
Entity Type: 03
Center for Genomic Interpretation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELEVATEGENETICS and VARIANT FACTCHECKER. The owner is based in Sandy, UT.
49 Wanderwood Way
Sandy, UT 84092
Showing of trademarks Trademarks
Trademark Classifications
Center for Genomic Interpretation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Center for Genomic Interpretation have?
Center for Genomic Interpretation has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does Center for Genomic Interpretation file in?
Center for Genomic Interpretation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Center for Genomic Interpretation's most well-known trademarks?
Center for Genomic Interpretation's registered trademark portfolio includes well-known marks such as ELEVATEGENETICS and VARIANT FACTCHECKER. These are among 2 currently registered trademarks in the portfolio.
What is Center for Genomic Interpretation's trademark registration success rate?
Center for Genomic Interpretation has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.